Catalyst Wire Dossier Catalyst Wire Dossier

Verteporfin (Visudyne)

verteporfin · Novartis
Drug timelines are a Plus or Pro feature.

6 regulatory and trial events tracked for Verteporfin (Visudyne), covering 2006-06-21 to 2026-03-23. Get the full timeline:

Most recent: Clinical Trial Update: SCARFREE-001: Verteporfin for Scar Prevention [Phase 2]

See pricing